Celprogen Inc., a global leader in the Stem Cell Research and Therapeutics industry for stem cell research since 2002, today announced that they have been awarded the ISO 9001-2015 Certification; the internationally recognized standards to ensures that our products and services meet the needs of our global clients through an effective quality management system.
Celprogen has developed and implemented their quality management system in order to improve the overall performance, maintain a high level of quality and strong customer service and to provide a sound basis for sustainable drug development initiatives as tested in their 3D human organ modeling systems, which includes the following major human organs: heart, brain, liver, kidney, pancreas, hair follicle and skin. The present inventions related to 3D organ printing programs at Celprogen identifies potential future uses in transplant of major organ systems.
Our decision to work towards ISO 9001:2015 accreditation demonstrates our commitment to providing high-quality and consistent products to our clients and our ongoing investment in technology and development.
About Celprogen Inc.
Celprogen Inc. is a global Stem Cell Research & Therapeutics company since 2002, which is developing a proprietary portfolio of unique therapeutics products and life science research tools that includes genetic engineering technologies, stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in Torrance, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell, Cancer Stem Cell and Primary Cell Culture products to serve our global community. Additional information about Celprogen is available at https://www.celprogen.com.